Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,287.00
-7.50 (-0.33%)
Jun 19, 2026, 2:25 PM JST
Rohto Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 18, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 518,475 | 544,009 | 505,369 | 676,888 | 631,946 | 421,488 | |
Market Cap Growth | 12.45% | 7.65% | -25.34% | 7.11% | 49.93% | 25.13% |
Enterprise Value | 510,249 | 539,100 | 493,570 | 610,616 | 575,682 | 380,505 |
Last Close Price | 2294.50 | 2407.50 | 2195.11 | 2874.10 | 2662.24 | 1759.75 |
PE Ratio | 15.79 | 15.89 | 16.30 | 21.88 | 23.96 | 20.05 |
Forward PE | 14.78 | 16.33 | 15.19 | 20.08 | 24.15 | 19.94 |
PS Ratio | 1.51 | 1.58 | 1.64 | 2.50 | 2.65 | 2.11 |
PB Ratio | 1.62 | 1.70 | 1.86 | 2.74 | 2.94 | 2.29 |
P/TBV Ratio | 2.38 | 2.50 | 2.48 | 2.86 | 3.16 | 2.49 |
P/FCF Ratio | 14.29 | 14.99 | 18.16 | 25.77 | 28.15 | 24.82 |
P/OCF Ratio | 10.85 | 11.38 | 13.69 | 19.77 | 20.43 | 15.47 |
PEG Ratio | 2.78 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 |
EV/Sales Ratio | 1.48 | 1.57 | 1.60 | 2.26 | 2.41 | 1.91 |
EV/EBITDA Ratio | 8.71 | 9.28 | 9.56 | 12.50 | 13.93 | 10.61 |
EV/EBIT Ratio | 12.38 | 13.24 | 12.83 | 15.20 | 17.17 | 13.50 |
EV/FCF Ratio | 14.06 | 14.85 | 17.73 | 23.25 | 25.64 | 22.41 |
Debt / Equity Ratio | 0.19 | 0.19 | 0.19 | 0.04 | 0.05 | 0.12 |
Debt / EBITDA Ratio | 1.04 | 1.04 | 0.97 | 0.21 | 0.28 | 0.60 |
Debt / FCF Ratio | 1.66 | 1.66 | 1.80 | 0.40 | 0.52 | 1.26 |
Net Debt / Equity Ratio | -0.08 | -0.08 | -0.10 | -0.32 | -0.32 | -0.28 |
Net Debt / EBITDA Ratio | -0.46 | -0.46 | -0.52 | -1.61 | -1.65 | -1.43 |
Net Debt / FCF Ratio | -0.73 | -0.73 | -0.97 | -3.00 | -3.04 | -3.03 |
Asset Turnover | 0.76 | 0.76 | 0.80 | 0.83 | 0.82 | 0.80 |
Inventory Turnover | 2.37 | 2.37 | 2.47 | 2.59 | 2.72 | 2.71 |
Quick Ratio | 1.40 | 1.40 | 1.55 | 1.82 | 1.75 | 1.74 |
Current Ratio | 2.04 | 2.04 | 2.30 | 2.47 | 2.37 | 2.30 |
Return on Equity (ROE) | 11.63% | 11.63% | 11.94% | 13.59% | 13.25% | 12.42% |
Return on Assets (ROA) | 5.61% | 5.61% | 6.26% | 7.66% | 7.17% | 7.04% |
Return on Invested Capital (ROIC) | 10.39% | 11.12% | 13.63% | 19.28% | 18.52% | 17.47% |
Return on Capital Employed (ROCE) | 11.00% | 11.00% | 11.80% | 15.50% | 14.60% | 13.90% |
Earnings Yield | 6.61% | 6.30% | 6.13% | 4.57% | 4.17% | 4.99% |
FCF Yield | 7.00% | 6.67% | 5.51% | 3.88% | 3.55% | 4.03% |
Dividend Yield | 2.16% | 1.91% | 1.64% | 0.94% | 0.83% | 1.02% |
Payout Ratio | 27.05% | 27.05% | 22.81% | 17.70% | 17.73% | 16.28% |
Buyback Yield / Dilution | -2.87% | -2.87% | -0.04% | 0.00% | 0.00% | - |
Total Shareholder Return | -0.71% | -0.96% | 1.60% | 0.94% | 0.83% | 1.02% |